Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen

Meng‐Hsing Wu, Pei-Chin Chuang, Hsiu‐Mei Chen, Shaw‐Jenq Tsai
In: Fertility and Sterility · 2003 · vol. 80 , pp. 34 · doi:10.1016/s0015-0282(03)01890-9 · W2071122278
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This study investigated fibroblast growth factor-9 expression and its mitogenic effect in human endometriotic implants, finding that aberrant estrogen production regulates these processes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK